134 related articles for article (PubMed ID: 2503683)
1. Inhibition of erythrocyte anion exchange by tolrestat, an inhibitor of aldose reductase.
Gunn RB; Gunn HB
Metabolism; 1989 Aug; 38(8):801-4. PubMed ID: 2503683
[TBL] [Abstract][Full Text] [Related]
2. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
[TBL] [Abstract][Full Text] [Related]
3. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.
Simard-Duquesne N; Greselin E; Dubuc J; Dvornik D
Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915
[TBL] [Abstract][Full Text] [Related]
4. N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.
Sestanj K; Bellini F; Fung S; Abraham N; Treasurywala A; Humber L; Simard-Duquesne N; Dvornik D
J Med Chem; 1984 Mar; 27(3):255-6. PubMed ID: 6422042
[No Abstract] [Full Text] [Related]
5. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
[TBL] [Abstract][Full Text] [Related]
6. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.
McCaleb ML; Sredy J; Millen J; Ackerman DM; Dvornik D
J Diabet Complications; 1988; 2(1):16-8. PubMed ID: 2968349
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase and retinal capillary basement membrane thickening.
Robison WG; Nagata M; Kinoshita JH
Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
[TBL] [Abstract][Full Text] [Related]
8. Determination of tolrestat, a novel aldose reductase inhibitor, in serum and tissues.
Hicks DR; Kraml M
Ther Drug Monit; 1984; 6(3):328-33. PubMed ID: 6438835
[TBL] [Abstract][Full Text] [Related]
9. Interactions of NIP-taurine, NAP-taurine, and Cl- with the human erythrocyte anion exchange system.
Knauf PA; Mann NA; Kalwas JE; Spinelli LJ; Ramjeesingh M
Am J Physiol; 1987 Nov; 253(5 Pt 1):C652-61. PubMed ID: 3688213
[TBL] [Abstract][Full Text] [Related]
10. Orally active aldose reductase inhibitors derived from bioisosteric substitutions on tolrestat.
Wrobel J; Millen J; Sredy J; Dietrich A; Kelly JM; Gorham BJ; Sestanj K
J Med Chem; 1989 Nov; 32(11):2493-500. PubMed ID: 2509709
[TBL] [Abstract][Full Text] [Related]
11. Effects of NaCl, glucose, and aldose reductase inhibitors on cloning efficiency of renal medullary cells.
Yancey PH; Burg MB; Bagnasco SM
Am J Physiol; 1990 Jan; 258(1 Pt 1):C156-63. PubMed ID: 2105652
[TBL] [Abstract][Full Text] [Related]
12. The polyol pathway in retinal microangiopathy.
Robison WG; Kinoshita JH; Kador PF
Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
[TBL] [Abstract][Full Text] [Related]
13. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats.
Bellomo G; Comstock JP; Wen D; Hazelwood RL
Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222
[TBL] [Abstract][Full Text] [Related]
14. A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy.
Boulton AJ; Levin S; Comstock J
Diabetologia; 1990 Jul; 33(7):431-7. PubMed ID: 2119323
[TBL] [Abstract][Full Text] [Related]
15. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG
Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
17. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aldehyde reductase by aldose reductase inhibitors.
Sato S; Kador PF
Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inorganic anion transport across the human red blood cell membrane by chloride-dependent association of dipyridamole with a stilbene disulfonate binding site on the band 3 protein.
Legrum B; Passow H
Biochim Biophys Acta; 1989 Feb; 979(2):193-207. PubMed ID: 2923878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
